Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuromyelitis Optica | 8 | 2023 | 22 | 2.940 |
Why?
|
Multiple Sclerosis | 9 | 2023 | 261 | 1.980 |
Why?
|
Immunologic Factors | 4 | 2020 | 170 | 1.060 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 4 | 2020 | 53 | 0.900 |
Why?
|
Premedication | 1 | 2018 | 54 | 0.680 |
Why?
|
Interferon Type I | 2 | 2011 | 175 | 0.640 |
Why?
|
Antibodies, Monoclonal, Humanized | 2 | 2018 | 929 | 0.510 |
Why?
|
Fenfluramine | 3 | 1999 | 20 | 0.500 |
Why?
|
Immunosuppressive Agents | 4 | 2023 | 977 | 0.490 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2014 | 3 | 0.490 |
Why?
|
Rituximab | 3 | 2023 | 116 | 0.470 |
Why?
|
Hemianopsia | 1 | 2012 | 4 | 0.440 |
Why?
|
Optic Nerve | 1 | 2012 | 35 | 0.430 |
Why?
|
Natalizumab | 3 | 2018 | 21 | 0.420 |
Why?
|
Retinal Ganglion Cells | 1 | 2012 | 66 | 0.410 |
Why?
|
Visual Pathways | 1 | 2012 | 152 | 0.400 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 78 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-fos | 4 | 2001 | 68 | 0.370 |
Why?
|
Optic Neuritis | 1 | 2009 | 10 | 0.360 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2011 | 206 | 0.360 |
Why?
|
Alemtuzumab | 2 | 2020 | 83 | 0.350 |
Why?
|
Aquaporin 4 | 2 | 2023 | 8 | 0.350 |
Why?
|
Myelitis, Transverse | 1 | 2008 | 10 | 0.330 |
Why?
|
Salivary Glands, Minor | 1 | 2008 | 9 | 0.330 |
Why?
|
Submandibular Gland Diseases | 1 | 2008 | 9 | 0.330 |
Why?
|
Serotonin Agents | 2 | 1999 | 12 | 0.330 |
Why?
|
Tomography, Optical Coherence | 3 | 2017 | 130 | 0.280 |
Why?
|
Recurrence | 2 | 2023 | 1137 | 0.230 |
Why?
|
Mycophenolic Acid | 1 | 2023 | 87 | 0.220 |
Why?
|
Inflammation | 1 | 2008 | 913 | 0.220 |
Why?
|
Azathioprine | 1 | 2023 | 125 | 0.220 |
Why?
|
Magnetic Resonance Imaging | 8 | 2023 | 3347 | 0.220 |
Why?
|
Humans | 22 | 2023 | 86281 | 0.210 |
Why?
|
Adult | 12 | 2020 | 25577 | 0.210 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 1562 | 0.200 |
Why?
|
Female | 15 | 2023 | 44405 | 0.190 |
Why?
|
White Matter | 2 | 2018 | 80 | 0.190 |
Why?
|
Hypothalamus | 2 | 2001 | 79 | 0.180 |
Why?
|
Serotonin Antagonists | 2 | 2001 | 35 | 0.170 |
Why?
|
Ranitidine | 1 | 2018 | 8 | 0.170 |
Why?
|
Cetirizine | 1 | 2018 | 12 | 0.170 |
Why?
|
Diphenhydramine | 1 | 2018 | 17 | 0.170 |
Why?
|
Administration, Intravenous | 1 | 2018 | 50 | 0.170 |
Why?
|
Methylprednisolone | 1 | 2018 | 66 | 0.170 |
Why?
|
Gray Matter | 1 | 2018 | 33 | 0.170 |
Why?
|
Acetaminophen | 1 | 2018 | 54 | 0.160 |
Why?
|
Neurotransmitter Agents | 1 | 1999 | 106 | 0.160 |
Why?
|
Amygdala | 1 | 1999 | 84 | 0.160 |
Why?
|
Male | 14 | 2020 | 40860 | 0.160 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2018 | 5 | 0.160 |
Why?
|
Lymphocytes | 1 | 2020 | 461 | 0.160 |
Why?
|
Limbic Encephalitis | 1 | 2018 | 11 | 0.160 |
Why?
|
Fenclonine | 1 | 1997 | 2 | 0.160 |
Why?
|
Glutamate Decarboxylase | 1 | 2018 | 32 | 0.160 |
Why?
|
Appetite Depressants | 1 | 1997 | 11 | 0.160 |
Why?
|
Retrospective Studies | 5 | 2023 | 8431 | 0.160 |
Why?
|
Serotonin | 1 | 1999 | 218 | 0.150 |
Why?
|
Encephalitis | 1 | 2018 | 104 | 0.150 |
Why?
|
Fluoxetine | 1 | 1997 | 42 | 0.150 |
Why?
|
Age Factors | 2 | 2020 | 1842 | 0.150 |
Why?
|
Prosencephalon | 1 | 1997 | 62 | 0.150 |
Why?
|
Middle Aged | 8 | 2020 | 24957 | 0.150 |
Why?
|
Brain Stem | 1 | 1997 | 165 | 0.150 |
Why?
|
B-Lymphocytes | 2 | 2020 | 724 | 0.150 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2018 | 120 | 0.140 |
Why?
|
Treatment Outcome | 4 | 2018 | 7949 | 0.140 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 339 | 0.140 |
Why?
|
Antibodies | 1 | 2018 | 349 | 0.140 |
Why?
|
Retina | 1 | 2017 | 212 | 0.140 |
Why?
|
Sex Factors | 1 | 2018 | 1053 | 0.130 |
Why?
|
Disease Progression | 2 | 2018 | 1531 | 0.130 |
Why?
|
Body Mass Index | 1 | 2018 | 770 | 0.130 |
Why?
|
Nerve Tissue Proteins | 1 | 1998 | 503 | 0.130 |
Why?
|
Brain | 3 | 2022 | 2211 | 0.130 |
Why?
|
Epilepsy | 1 | 2018 | 395 | 0.120 |
Why?
|
Aquaporins | 1 | 2012 | 14 | 0.110 |
Why?
|
Autoantibodies | 2 | 2018 | 267 | 0.110 |
Why?
|
Visual Field Tests | 1 | 2012 | 14 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 4 | 2001 | 1214 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2022 | 456 | 0.110 |
Why?
|
Neurons | 2 | 2001 | 1545 | 0.100 |
Why?
|
Escherichia coli Proteins | 1 | 2012 | 179 | 0.100 |
Why?
|
Prevalence | 2 | 2020 | 1239 | 0.100 |
Why?
|
Glatiramer Acetate | 1 | 2009 | 14 | 0.090 |
Why?
|
Receptors, Serotonin | 2 | 2001 | 34 | 0.090 |
Why?
|
Young Adult | 2 | 2018 | 5961 | 0.090 |
Why?
|
Mitoxantrone | 1 | 2009 | 68 | 0.090 |
Why?
|
Adolescent | 3 | 2017 | 8968 | 0.090 |
Why?
|
Thalamus | 2 | 2022 | 132 | 0.090 |
Why?
|
Rats | 4 | 2001 | 3984 | 0.090 |
Why?
|
Interferon-beta | 1 | 2009 | 125 | 0.090 |
Why?
|
Up-Regulation | 1 | 2011 | 710 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2012 | 1014 | 0.080 |
Why?
|
Sjogren's Syndrome | 1 | 2008 | 30 | 0.080 |
Why?
|
Organ Size | 2 | 2018 | 363 | 0.080 |
Why?
|
Animals | 6 | 2014 | 26518 | 0.070 |
Why?
|
Antibodies, Monoclonal | 2 | 2009 | 1376 | 0.070 |
Why?
|
Peptides | 1 | 2009 | 639 | 0.070 |
Why?
|
Biomarkers | 1 | 2011 | 1709 | 0.070 |
Why?
|
Follow-Up Studies | 1 | 2012 | 3616 | 0.070 |
Why?
|
Biopsy | 1 | 2008 | 1160 | 0.060 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2001 | 44 | 0.060 |
Why?
|
Limbic System | 1 | 2022 | 23 | 0.060 |
Why?
|
Paraventricular Hypothalamic Nucleus | 2 | 2001 | 7 | 0.050 |
Why?
|
Oxytocin | 2 | 2001 | 71 | 0.050 |
Why?
|
Corticosterone | 1 | 2001 | 35 | 0.050 |
Why?
|
Renin | 1 | 2001 | 78 | 0.050 |
Why?
|
Neuropeptides | 1 | 2001 | 112 | 0.050 |
Why?
|
Vitamin D | 1 | 2023 | 261 | 0.050 |
Why?
|
Prospective Studies | 2 | 2020 | 4194 | 0.050 |
Why?
|
Immunophenotyping | 1 | 2020 | 211 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2020 | 136 | 0.050 |
Why?
|
Child | 1 | 2010 | 6913 | 0.040 |
Why?
|
Enkephalins | 1 | 1999 | 16 | 0.040 |
Why?
|
Neurotensin | 1 | 1999 | 10 | 0.040 |
Why?
|
Ritanserin | 1 | 1998 | 1 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2018 | 56 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 267 | 0.040 |
Why?
|
Atrophy | 1 | 2018 | 117 | 0.040 |
Why?
|
Carboxy-Lyases | 1 | 2018 | 22 | 0.040 |
Why?
|
Lymphocyte Depletion | 1 | 2018 | 97 | 0.040 |
Why?
|
Gyrus Cinguli | 1 | 1997 | 45 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2020 | 373 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2018 | 318 | 0.040 |
Why?
|
Frontal Lobe | 1 | 1997 | 130 | 0.040 |
Why?
|
Temporal Lobe | 1 | 2018 | 172 | 0.040 |
Why?
|
Comorbidity | 1 | 2020 | 943 | 0.040 |
Why?
|
Personality | 1 | 2018 | 133 | 0.040 |
Why?
|
Piperazines | 1 | 1998 | 272 | 0.040 |
Why?
|
Pattern Recognition, Automated | 1 | 2017 | 217 | 0.040 |
Why?
|
Pyridines | 1 | 1998 | 309 | 0.030 |
Why?
|
Seizures | 1 | 2018 | 293 | 0.030 |
Why?
|
Hospitalization | 1 | 2020 | 844 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2018 | 1015 | 0.030 |
Why?
|
Pilot Projects | 1 | 2017 | 837 | 0.030 |
Why?
|
Pandemics | 1 | 2020 | 739 | 0.030 |
Why?
|
Phenotype | 1 | 2020 | 2375 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2020 | 1195 | 0.030 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2012 | 44 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2012 | 19 | 0.030 |
Why?
|
Cross Reactions | 1 | 2012 | 106 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 1610 | 0.030 |
Why?
|
Rabbits | 1 | 2012 | 636 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2012 | 615 | 0.020 |
Why?
|
Risk Factors | 1 | 2020 | 5397 | 0.020 |
Why?
|
Time Factors | 1 | 2018 | 5198 | 0.020 |
Why?
|
Algorithms | 1 | 2017 | 1828 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 2062 | 0.020 |
Why?
|
United States | 1 | 2020 | 6637 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 3029 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2012 | 2810 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 893 | 0.020 |
Why?
|
Aged | 1 | 2020 | 18353 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2001 | 2 | 0.010 |
Why?
|
Serotonin Receptor Agonists | 1 | 2001 | 15 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2001 | 14 | 0.010 |
Why?
|
Prolactin | 1 | 2001 | 88 | 0.010 |
Why?
|
Fluorobenzenes | 1 | 2001 | 33 | 0.010 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2001 | 131 | 0.010 |
Why?
|
Piperidines | 1 | 2001 | 181 | 0.010 |
Why?
|
Mice | 1 | 2012 | 11313 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 1958 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2001 | 1752 | 0.010 |
Why?
|